
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Recombinant Subunit B Bacterial Cholera Vaccine
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Recombinant Subunit B Bacterial Cholera Vaccine is a vaccine drug candidate, which is currently being evaluated in Phase IV clinical studies for the treatment of Diarrhea.
Product Name : Undisclosed
Product Type : Vaccine
Upfront Cash : Inapplicable
December 23, 2025
Lead Product(s) : Recombinant Subunit B Bacterial Cholera Vaccine
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
